Dominant Fecal Microbiota in Newly Diagnosed Untreated Inflammatory Bowel Disease Patients

Overview

Journal Gastroenterol Res Pract

Publisher Wiley

Specialty Gastroenterology

Date 2013 Dec 19

PMID 24348539

Citations 29

Authors

Lill Therese Thorkildsen

Felix Chinweije Nwosu

Ekaterina Avershina

Petr Ricanek

Gori Perminow

Stephan Brackmann

Morten H Vatn

Knut Rudi

Affiliations

Soon will be listed here.

Abstract

Our knowledge about the microbiota associated with the onset of IBD is limited. The aim of our study was to investigate the correlation between IBD and the fecal microbiota for early diagnosed untreated patients. The fecal samples used were a part of the Inflammatory Bowel South-Eastern Norway II (IBSEN II) study and were collected from CD patients (n = 30), UC patients (n = 33), unclassified IBD (IBDU) patients (n = 3), and from a control group (n = 34). The bacteria associated with the fecal samples were analyzed using a direct 16S rRNA gene-sequencing approach combined with a multivariate curve resolution (MCR) analysis. In addition, a 16S rRNA gene clone library was prepared for the construction of bacteria-specific gene-targeted single nucleotide primer extension (SNuPE) probes. The MCR analysis resulted in the recovery of five pure components of the dominant bacteria present: Escherichia/Shigella, Faecalibacterium, Bacteroides, and two components of unclassified Clostridiales. Escherichia/Shigella was found to be significantly increased in CD patients compared to control subjects, and Faecalibacterium was found to be significantly reduced in CD patients compared to both UC patients and control subjects. Furthermore, a SNuPE probe specific for Escherichia/Shigella showed a significant overrepresentation of Escherichia/Shigella in CD patients compared to control subjects. In conclusion, samples from CD patients exhibited an increase in Escherichia/Shigella and a decrease in Faecalibacterium indicating that the onset of the disease is associated with an increase in proinflammatory and a decrease in anti-inflammatory bacteria.

Citing Articles

Interrelationships of the Intestinal Microbiome, Trimethylamine N-Oxide and Lipopolysaccharide-Binding Protein with Crohn's Disease Activity.

Laryushina Y, Samoilova-Bedych N, Turgunova L, Marchenko A, Turgunov Y, Kozhakhmetov S Pathogens. 2025; 14(1).

PMID: 39860966 PMC: 11768583. DOI: 10.3390/pathogens14010005.

Chemical Profile and In Vitro Gut Microbiota Modulation of Wild Edible Mushroom Fruiting Body at Different Maturity Stages.

Kaewsaen R, Wichienchot S, Thayanukul P, Charoensiddhi S, Chanput W Nutrients. 2024; 16(15).

PMID: 39125432 PMC: 11313837. DOI: 10.3390/nu16152553.

Elemental iron protects gut microbiota against oxygen-induced dysbiosis.

Ostrov I, Gong Y, Zuk J, Wickramasinghe P, Tmenova I, Roopchand D PLoS One. 2024; 19(2):e0298592.

PMID: 38412144 PMC: 10898728. DOI: 10.1371/journal.pone.0298592.

Coronavirus Disease 2019 (COVID-19) Pandemic Lifestyle Changes May Have Influenced Small Bowel Microbial Composition and Microbial Resistance.

Hosseini A, Rashid M, Leite G, Barlow G, Parodi G, Sanchez M Dig Dis Sci. 2023; 68(10):3902-3912.

PMID: 37578565 PMC: 10516792. DOI: 10.1007/s10620-023-08061-6.

Effects of Softening Dry Food with Water on Stress Response, Intestinal Microbiome, and Metabolic Profile in Beagle Dogs.

Zhang L, Yang K, Jian S, Xin Z, Wen C, Zhang L Metabolites. 2022; 12(11).

PMID: 36422265 PMC: 9697261. DOI: 10.3390/metabo12111124.

References

Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R . Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 2007; 1(5):403-18. DOI: 10.1038/ismej.2007.52. View

Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S . Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2009; 22(5):512-9, e114-5. DOI: 10.1111/j.1365-2982.2009.01427.x. View

Sartor R . Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006; 3(7):390-407. DOI: 10.1038/ncpgasthep0528. View

Rolhion N, Darfeuille-Michaud A . Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13(10):1277-83. DOI: 10.1002/ibd.20176. View

Rodriguez L, Ruigomez A, Panes J . Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. 2006; 130(6):1588-94. DOI: 10.1053/j.gastro.2006.02.004. View

Duncan S, Louis P, Flint H . Cultivable bacterial diversity from the human colon. Lett Appl Microbiol. 2007; 44(4):343-50. DOI: 10.1111/j.1472-765X.2007.02129.x. View

Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, Aerts R . Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 1991; 338(8770):771-4. DOI: 10.1016/0140-6736(91)90663-a. View

Round J, Mazmanian S . The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009; 9(5):313-23. PMC: 4095778. DOI: 10.1038/nri2515. View

Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P . Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003; 52(2):237-42. PMC: 1774977. DOI: 10.1136/gut.52.2.237. View

10.

Sokol H, Seksik P, Furet J, Firmesse O, Nion-Larmurier I, Beaugerie L . Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009; 15(8):1183-9. DOI: 10.1002/ibd.20903. View

11.

Zhang M, Liu B, Zhang Y, Wei H, Lei Y, Zhao L . Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis. J Clin Microbiol. 2006; 45(2):496-500. PMC: 1829069. DOI: 10.1128/JCM.01720-06. View

12.

Walker A, Sanderson J, Churcher C, Parkes G, Hudspith B, Rayment N . High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011; 11:7. PMC: 3032643. DOI: 10.1186/1471-2180-11-7. View

13.

Hansen R, Russell R, Reiff C, Louis P, McIntosh F, Berry S . Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol. 2012; 107(12):1913-22. DOI: 10.1038/ajg.2012.335. View

14.

Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran L, Gratadoux J . Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105(43):16731-6. PMC: 2575488. DOI: 10.1073/pnas.0804812105. View

15.

Haas B, Gevers D, Earl A, Feldgarden M, Ward D, Giannoukos G . Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011; 21(3):494-504. PMC: 3044863. DOI: 10.1101/gr.112730.110. View

16.

Shanahan F, Bernstein C . The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol. 2009; 25(4):301-5. DOI: 10.1097/MOG.0b013e32832b12ef. View

17.

Ley R, Turnbaugh P, Klein S, Gordon J . Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444(7122):1022-3. DOI: 10.1038/4441022a. View

18.

Mondot S, Kang S, Furet J, Aguirre de Carcer D, McSweeney C, Morrison M . Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis. 2010; 17(1):185-92. DOI: 10.1002/ibd.21436. View

19.

Lupp C, Robertson M, Wickham M, Sekirov I, Champion O, Gaynor E . Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe. 2007; 2(2):119-29. DOI: 10.1016/j.chom.2007.06.010. View

20.

Segain J, D Raingeard de la Bletiere , Bourreille A, Leray V, Gervois N, Rosales C . Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut. 2000; 47(3):397-403. PMC: 1728045. DOI: 10.1136/gut.47.3.397. View